Research Groups and R&D Platforms: Diagnostics
Research Group:
Cytoskeletal and survival signaling
John Eriksson
john.eriksson[at]abo.fi
Turku Bioscience Centre &
Cell Biology, Faculty of Science and Engineering,
Åbo Akademi University
Cytoskeletal and survival signaling
Atomic-force microscopy, Basic research, Biochemistry, Cancer, Diabetes, Diagnostics, Electron microscopy, High throughput imaging, Imaging, In Vitro Diagnostics, Metabolic diseases, Molecular Biology, Molecular Cell Biology, Nanoparticles, Natural Compounds, Natural products, Physiology, Proteomics, Receptor, Signaling, Super-resolution imaging, Target discovery
R&D Platform:
Center for Functional Materials (FUNMAT)
FUNMAT is a research center in functional materials based at Åbo Akademi University. FUNMAT is combining the expertise in chemistry, physics, biology, paper coating and printing to develop functional materials, devices and large area manufacturing for interfacing with biological systems. The multidisciplinary research is done in close collaboration with industry and our extensive collaboration network throughout the world.
Basic research, Biochemistry, Diagnostics, Drug delivery, Drug solubility, Formulation, Nanoparticles, Pharmacy, Physics, Preclinical development, R&D Platforms
Research Group:
Novel multitargeting therapies for neurodegenerative diseases
Timo Myöhänen
timo.myohanen[at]utu.fi
Institute of Biomedicine,
University of Turku
PREP in Neurodegenerative Disorders (Helsinki-group page)
Ageing-related diseases, Assay development, Basic research, Biomedicine, Diagnostics, Disease models, Drug target, Imaging software, In Vitro Diagnostics, In Vivo Diagnostics, MALS or SEC-MALS, Medicinal chemistry, Molecular Biology, Molecular modelling, Neurological disorders, PET, Pharmacology, Signaling, Target discovery
Research Group:
Recombinant antibodies and other bioaffinity molecules
Urpo Lamminmäki
urplammi[at]utu.fi
Department of Life Technologies,
University of Turku
Antibodies, Assay development, Basic research, Biomarker, Biotechnology, Cancer, Combinatorial chemistry, Diagnostics, Drug target, Fluorescence spectroscopy, Hit to lead, In Vitro Diagnostics, Infection, Lead optimization, Metabolic diseases, Molecular Biology, Molecular modelling, Nanoparticles, Next-generation sequencing, Ovarian cancer, Point of care, Prostate cancer, Screening, Synthetic Biology, Target discovery
